Overview IGC is a Maryland corporation established in 2005 with a fiscal year ending on March 31, spanning a 52- or 53-week period. Please refer to Note 1, Nature of Operations and Item 8 of this Annual Report on Form 10-K, for further information on business segments. Our mission is to improve the lives of individuals affected by Alzheimers disease by addressing both its symptoms and the disease. Our near-term focus is on advancing IGC-AD1, our lead drug candidate currently in Phase 2 clinical ...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-06-27 | 2025-03-31 | 0001185185-25-000706 | EDGAR | 60K words |
| 2024-06-24 | 2024-03-31 | 0001185185-24-000650 | EDGAR | — |
| 2023-07-07 | 2023-03-31 | 0001185185-23-000693 | EDGAR | — |
| 2022-06-23 | 2022-03-31 | 0001185185-22-000768 | EDGAR | — |
| 2021-06-14 | 2021-03-31 | 0001185185-21-000802 | EDGAR | — |
| 2020-07-13 | 2020-03-31 | 0001185185-20-000984 | EDGAR | — |
| 2019-06-14 | 2019-03-31 | 0001185185-19-000890 | EDGAR | — |
| 2018-06-21 | 2018-03-31 | 0001185185-18-001155 | EDGAR | — |
| 2017-07-14 | 2017-03-31 | 0001185185-17-001544 | EDGAR | — |
| 2016-07-14 | 2016-03-31 | 0001185185-16-004982 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001185185-25-001752 | EDGAR | 21K words |
| 2025-08-14 | 2025-06-30 | 0001185185-25-000997 | EDGAR | — |
| 2025-02-14 | 2024-12-31 | 0001185185-25-000137 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001185185-24-001096 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0001185185-24-000766 | EDGAR | — |
| 2024-02-14 | 2023-12-31 | 0001185185-24-000160 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001185185-23-001163 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001185185-23-000796 | EDGAR | — |
| 2023-02-14 | 2022-12-31 | 0001185185-23-000133 | EDGAR | — |
| 2022-11-01 | 2022-09-30 | 0001185185-22-001243 | EDGAR | — |
| 2022-08-05 | 2022-06-30 | 0001185185-22-000890 | EDGAR | — |
| 2022-02-10 | 2021-12-31 | 0001185185-22-000162 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0001185185-26-001146 | EDGAR | 1K words |
| 2026-03-12 | 0001185185-26-000846 | EDGAR | — |
| 2026-01-06 | 0001185185-26-000032 | EDGAR | — |
| 2026-01-02 | 0001185185-26-000010 | EDGAR | — |
| 2025-12-15 | 0001185185-25-002055 | EDGAR | — |
| 2025-11-14 | 0001185185-25-001713 | EDGAR | — |
| 2025-10-14 | 0001185185-25-001428 | EDGAR | — |
| 2025-10-01 | 0001185185-25-001326 | EDGAR | — |
| 2025-06-17 | 0001185185-25-000657 | EDGAR | — |
| 2024-09-27 | 0001185185-24-000923 | EDGAR | — |
345 total filings indexed. 313 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001326205 |
| Ticker | IGC |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | MD |
| Website | https://www.igcinc.us |
| Listed | 2006-04-13 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report